Durvalumab vs Topiramate

## Durvalumab vs Topiramate: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Topiramate**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Topiramate**: Multiple mechanisms: Na+ channel block, GABA enhancement, glutamate inhibition.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Topiramate — 21 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Topiramate — C12H21NO8S.

**Molecular Weight**: Durvalumab — N/A; Topiramate — 339.3630 g/mol.

**Type**: Durvalumab — Antibody; Topiramate — Small molecule.